These times were assessed as predictors of inpatient mortality

These times were assessed as predictors of inpatient mortality. analyzed. The median incubation time was 32.1 h and was associated with mortality (univariate risk ratio per hour, NBTGR 1.025;P= 0.001). The median supplier notification and antifungal initiation periods were 0.3 and 7.5 h, respectively, and were not associated with mortality. Adjusted analysis yielded similar results. For malignancy individuals with candidemia, the incubation period accounts for a significant amount of time, compared with the supplier notification and antifungal initiation occasions, and is associated with in-hospital mortality. Strategies to shorten the incubation time, such as utilizing quick molecularly centered diagnostic methods, may help reduce in-hospital mortality. Candidemia has been reported to become the fourth most common hospital-associated bloodstream infection in the United States (48). Estimates of its attributable mortality are substantial (14,47). Among cancer patients, candidemia also contributes to overall mortality. According to one study, candidemia was thought to play either a primary or a secondary role in about two-thirds of all deaths in infected cancer patients (46). For the general patient with candidemia, reported predictors of mortality include, but are not limited to, age, duration of hospitalization, severity-of-illness score, acute renal failure, intensive care unit (ICU) stay, retention of a central venous catheter, mechanical ventilation, non-Candida albicans Candidaspecies, and persistence of the candidemia (5,11,21,28). These variables are also risk factors in the cancer patient population, with some additional predictors: neutropenia, hematologic malignancy, visceral dissemination, poor performance status, and stage of disease (2,29,43). In addition to all of these associations, two studies that were performed on general patients with candidemia have demonstrated that a delay NBTGR in antifungal therapy is usually associated with an increase in mortality (13,27). In both of these studies, delays were analyzed by measuring the time from blood culture collection to the initiation of antifungal therapy. However, during this overall time interval, several different events occur: the collected blood culture incubates until it becomes positive; the positive result is usually conveyed to the health care provider, who NBTGR interprets its clinical significance; the health care provider decides whether to prescribe therapy, and if so, the drug has to be administered to the patient. Although the overall time interval has been demonstrated to be associated with mortality, it is not clear if a delay in one, two, or all of these components leads to the observed increased mortality, since no prior studies have examined these events separately. In addition, no prior studies have examined antifungal delay specifically for the cancer patient population. In this study, we sought to measure the duration of each event occurring from blood culture collection to the initiation of antifungal therapy in episodes of candidemia in cancer patients and to see which, if any, of these Angiotensin Acetate events were associated with mortality. == MATERIALS AND METHODS == == Study population and design. == A historical cohort study was performed at Memorial Sloan-Kettering Cancer Center, a 432-bed tertiary cancer center located in New York City. Subjects of the study consisted of patients who had at least one blood culture positive forCandidaspecies from 1 January 2005 to 31 December 2007. The outcome of interest was in-hospital death. If a patient had multiple blood cultures positive forCandidaduring a hospitalization, only the first blood culture was counted as an observation. Subjects were excluded if the patient died prior to the culture result, if no antifungal treatment was given, or if the patient was already on preexisting systemic antifungal therapy at the time of blood culture collection. The study was approved by our institutional review board. == Blood culture protocol. == Our institution employs the Becton Dickinson BACTEC 9240 instrumented blood culture system, which provides continuous automated fluorescent monitoring of drawn blood cultures NBTGR for the growth of microorganisms. When a blood culture becomes positive, the microbiology staff performs initial microscopic assessment. Our hospital protocol requires that, in addition to entering these findings into the laboratory system, the staff notify the patient’s health care provider of the results by phone. Beginning in August 2006, our institution began routine antifungal susceptibility testing of allCandidaspecies isolated from blood culture. == Data collection. == For each episode of candidemia, the following were recorded: date and time of blood culture collection, date and time of blood culture positivity, date and time of health care NBTGR provider notification, and date and time of administration of the first antifungal agent..